Plecanatide
Who holds supplier records for Plecanatide? 6 organisations hold a current record for Plecanatide: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (2) and China (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Plecanatide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/plecanatide
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Plecanatide expires 5 Jun 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Plecanatide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALP PHARM BEIJING CO LTDActive DMF 35439 · latest filing Dec 2020
- AURO PEPTIDES LTDActive DMF 36321 · latest filing Sept 2021
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDCompany GMP cert on recordActive DMF 41493 · latest filing Mar 2025
- Hybio Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 42062 · latest filing Jun 2025
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 34227 · latest filing Nov 2019
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 34049 · latest filing Sept 2019
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Plecanatide). The latest listed patent expires 5 Jun 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Plecanatide is a synthetic analog of uroguanylin, a natural human peptide, which activates guanylate cyclase-C on the luminal surface of intestinal epithelial cells to stimulate cGMP production, leading to increased intestinal fluid secretion and transit. It is used in the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).
Chemical identity
- IUPAC name
- (2S)-2-[[(1R,4S,7S,10S,13S,16R,19S,22S,25R,32S,38R)-10-(2-amino-2-oxoethyl)-25-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]amino]butanoyl]amino]-22-(2-carboxyethyl)-32-[(1R)-1-hydroxyethyl]-4-methyl-19-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36-undecaoxo-7,13-di(propan-2-yl)-27,28,40,41-tetrathia-2,5,8,11,14,17,20,23,31,34,37-undecazabicyclo[14.13.13]dotetracontane-38-carbonyl]amino]-4-methylpentanoic acid
- Canonical SMILES
- C[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N
- InChIKey
- NSPHQWLKCGGCQR-DLJDZFDSSA-N
- Synonyms
- Trulance API, guanilib, sp-304 (synergy), trulance
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Guanylate Cyclase-C Agonist
- Mechanism of action
- Guanylate Cyclase Activators
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Plecanatide?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Plecanatide: ALP PHARM BEIJING CO LTD, AURO PEPTIDES LTD, CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD, Hybio Pharmaceutical Co., Ltd. (China), MATRIX PHARMACORP PRIVATE LTD (India) and MSN LIFE SCIENCES PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Plecanatide Drug Master Files are active?
ALP PHARM BEIJING CO LTD (DMF 35439), AURO PEPTIDES LTD (DMF 36321), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD (DMF 41493), Hybio Pharmaceutical Co., Ltd. (DMF 42062), MATRIX PHARMACORP PRIVATE LTD (DMF 34227) and MSN LIFE SCIENCES PRIVATE LIMITED (DMF 34049). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Plecanatide?
Yes. The latest patent listed for an approved US product containing Plecanatide expires 5 Jun 2034, across 1 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Plecanatide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Plecanatide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.